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ABSTRACT The carboxylic ionophores monensin and niger-
icin, at concentrations higher than 10 and 6 auM, respectively,
prevent the penetration of the Semliki Forest virus (SFV) genome
into the cytosol ofbaby hamster kidney (BHK-21) cells and thereby
inhibit viral replication. In the absence of inhibitors, the entry of
SFV is known to proceed by adsorptive endocytosis in coated ves-
icles, followed by acid-triggered membrane fusion in intracellular
vacuoles or lysosomes. The results show that binding of the virus
to the cell surface, adsorptive endocytosis, and intracellular trans-
port of viruses to the lysosomes are only marginally affected by
the ionophores. No direct virucidal effect is observed, nor is the
membrane fusion activity of the virus at low pH directly affected.
Sequential addition of monensin and ammonium chloride (a non-
related lysosomotropic inhibitor of SFV entry) indicates that both
inhibitors affect the same step in the entry pathway. On the basis
of these data and the known effects of carboxylic ionophores and
lysosomotropic weak bases on cellular pH gradients, we conclude
that monensin inhibits penetration by increasing the pH in en-
docytic vacuoles and lysosomes above pH 6, which is the pH
threshold for the viral membrane fusion activity.
Monensin and nigericin are carboxylic ionophores that inter-
calate into membranes and abolish proton gradients by electro-
neutral transmembrane exchange of protons for monovalent
cations (1). When added to cells, monensin causes a variety of
effects depending on cell-type, concentration, and time of in-
cubation. These include inhibition of protein secretion, the
transport of plasma membrane glycoproteins to the cell surface
(2-4), serum low density lipoprotein uptake and degradation
(5), membrane protein recycling (5, 6), and fluid-phase endo-
cytosis (6). It has also been shown that monensin blocks the
entry of vesicular stomatitis virus and diphtheria toxin into tis-
sue culture cells (7, 8).
In this study we have examined the effects of monensin and
nigericin on the entry of Semliki Forest virus (SFV) into baby
hamster kidney (BHK-21) cells. This simple enveloped virus is
internalized by an endocytic pathway that involves coated pits,
coated vesicles, endosomes, and secondary lysosomes (9, 10).
Penetration of the viral genome into the cytosol occurs when
the virus reaches an organelle with a pH < 6. The mildly acidic
pH induces a potent membrane fusion activity in the virus that
results in a fusion reaction between the viral membrane and the
vacuolar membrane (11, 12). The nucleocapsids are thereby
transferred into the cytoplasmic compartment. Nonfused vi-
ruses and viral membrane proteins are subsequently degraded
in the lysosomes (10).
Our results indicate that the principal effect ofmonensin (and
possibly nigericin, for which our data is less complete) during
virus entry is to inhibit the penetration ofthe viral nucleocapsid
from the intracellular vacuoles into the cytosol.
MATERIALS AND METHODS
Cells, Virus, and Inhibitors. BHK-21 cells were grown in
Glasgow minimum essential medium as described (9). A pro-
totype strain of SFV, [3S]methionine-labeled SFV (35S-SFV),
and [32P]orthophosphate-labeled SFV (32P-SFV) were propa-
gated in BHK-21 cells (13, 14). The 32P-SFV had 50% of the
radioactivity in the RNA and 50% in the phospholipid. Mo-
nensin and nigericin were purchased from Calbiochem. Viral
infection was assayed by incorporation of [3H]uridine into acid-
precipitable viral RNA as described (15).
Binding, Endocytosis, and Degradation. Binding, endocy-
tosis, and degradation of 3S-SFV was determined as described
(10). Proteinase K digestion was used to distinguish between
surface-bound and internalized viruses (10).
Cell Fractionation. BHK-21 cells were fractionated by free-
flow electrophoresis as described (16). Briefly, after incubation
with 32P-SFV for 1.5 hr at 370C, the cells were harvested by
scraping in phosphate-buffered saline and washed twice in lysis
buffer (0.25 M sucrose/10 mM triethanolamine/10 mM acetic
acid/i mM EDTA, pH 7.4). The cells were lysed on ice by 20
passes through a 10-ml glass pipette. Intact cells (30%), nuclei,
and aggregates were removed by three successive 10-min cen-
trifugations at 750, 850, and 950 X g, and the lysate was passed
through one layer of prewashed filter paper (Schleicher and
Schuell, no. 589/3). The filtrate was incubated with L-(tosylam-
ido-2-phenyl)ethyl chloromethyl ketone-treated trypsin (10 ,ug
ml'1; Worthington) for 3 min at 370C before addition ofsoybean
trypsin inhibitor (20
-,g ml-'; Sigma). The lysates were frac-
tionated by free-flow electrophoresis, and the fractions were
assayed for organelle enzyme markers as described (16) and for
radioactivity.
Microscopy. For electron microscopy of thin sections, the
cells were fixed by using 2.5% glutaraldehyde in 0.05 M cac-
odylate buffer (pH 7.2). Dehydration, sectioning, and staining
were performed as described (9).
RESULTS
Monensin and Nigericin Inhibit SFV Infectivity. It has been
shown (17) that addition of 1 ,uM monensin to SFV-infected cells
inhibits the formation of progeny virus by blocking a late event
in the replication cycle. The viral components are synthesized,
Abbreviations: SFV, Semliki Forest virus; BHK, baby hamster kidney;
moi, multiplicity of infection; pfu, plaque-forming unit(s); INT, 3-(4-io-
dophenyl)-2-(4-nitrophenyl)-5-phenyl-2H-tetrazolium chloride; -"S-SFV,
[35S]methionine-labeled SFV; 32P-SFV, [32P]orthophosphate-la-beled SFV.
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but virus maturation is inhibited because the spike glycopro-
teins are not transported to the cell surface (17, 18). Thus, to
study the effects of monensin and nigericin on early stages of
infection, we measured incorporation of [3H]uridine into viral
RNA. This assay monitors virus entry without relying on the
production ofprogeny virus (15, 19). We found that, in addition
to the effect on virus maturation (17, 18), the ionophores in-
hibited an early step in the replication cycle prior to initial RNA
synthesis. This effect required higher ionophore concentra-
tions. With 10 AM monensin or 3 AM nigericin, incorporation
of [3H]uridine into viral RNA was inhibited by -60% (Fig. 1).
With 1.0 AM monensin, the incorporation of[3H]uridine was
not inhibited but reproducibly exceeded that observed in un-
treated control cells (Fig. 1). This increase in labeling of viral
RNA in the presence of low monensin concentrations was con-
sistent with a block in virus maturation (17) because, unlike the
control cells, no labeled RNA was expected to be lost from
monensin-treated cells in the form of mature virus. This inter-
pretation was supported by experiments in which 1.0 ,M mo-
nensin was added 3 hr after infection instead of 20 min prior to
infection. The same increase in incorporation was observed,
indicating that, when maturation is inhibited, more labeled viral
RNA remains associated with the cell. Most of the subsequent
studies used 10 ,M monensin and, to prevent discrepancies
arising from loss of radioactivity through virus maturation, the
inhibitor was included in all samples during the period of
[3H]uridine labeling.
The efficiency of inhibition depended on the time of mo-
nensin addition. No inhibition was detected when 10 p.M mo-
nensin was added simultaneously with the SFV inoculum,
whereas 60 min of prior incubation gave 85% inhibition. With
25 p.M monensin, a 5-min preincubation was sufficient for full
inhibition, whereas 1.0 p.M monensin was without effect after
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FIG. 1. Effect of monensin and nigericin on viral RNA-synthesis.
Cells were preincubated at 37TC with medium containing monensin
(A) or nigericin (A). The medium was removed after 20 min, and the
cells were infected with SFV [20 plaque-forming units (pfu)/cell] for
90 min. Subsequently, the cells were incubated for 30 min in medium
containing actinomycin D (2 Ag ml-1) and finally in medium contain-
ing actinomycin D and [3Hluridine. Monensin or nigericin was present
throughout. The cells were washed and precipitated with trichloro-
acetic acid, and the [5H]uridine incorporation was determined. Incor-
poration is expressed as a percentage of the [3H]uridine incorporation
into SFV-infected cells in the absence of ionophore (100% is equivalent
to 15,000 cpm).
120 min of preincubation. The lack of inhibition with 10 A.M
monensin and SFV added simultaneously to cells indicated that
monensin had no direct virucidal effect. Apparently all of the
viral functions in entry were intact in spite of the presence of
monensin. When 25 AM monensin was added 2.5 hr after in-
fection (i.e., when virus entry had already taken place),
[3H]uridine incorporation into viral RNA was unaffected. Sim-
ilarly, monensin (25 p.M) had no effect on [3H]uridine incor-
poration into cellular RNA in the absence ofvirus. These results
indicate that monensin blocks a step in the virus entry pathway
prior to the onset ofRNA replication and that it does not directly
affect the functions of the virus particle or the RNA replication
process.
Bypass of the Monensin Block. SFV penetration into BHK-
21 cells is inhibited by lysosomotropic weak bases, this inhi-
bition can be bypassed by artificially induced fusion of the vi-
ruses with the plasma membrane at pH 5.5 (9, 12, 15). To see
whether the monensin block could be similarly bypassed, SFV
in the presence of 10 A.M monensin was bound to duplicate
wells of monensin-treated cells. To induce fusion, the medium
in one well was replaced with pH 5.5 medium (containing mo-
nensin) for 1 min. The other well served as a control and was
kept at pH 7.0 throughout. The cells were then incubated for
2 hr in the presence of monensin and assayed for viral RNA
synthesis. Table 1 shows that the cells treated at pH 5.5 were
infected in the continuous presence ofmonensin, whereas cells
kept at neutral pH throughout were inhibited.
This result confirms that monensin has no direct virucidal
effect and does not affect the low pH-dependent fusion activity
of the virus as such. In addition, it demonstrates that the viral
genome, when introduced into the cytosol in the presence of
monensin, is fully capable of uncoating and serving as messen-
ger for initial protein synthesis and as a template for RNA
replication.
In view of these findings, the most likely explanation for the
early inhibitory effect of monensin is that the viral RNA does
not reach the cytoplasmic matrix. To test this possibility di-
rectly, we relied on the sensitivity to RNase of uncoated nu-
cleocapsids (15). We determined the fraction of parental
[32P]RNA accessible to RNase in isotonic lysates ofcells that had
been incubated prior to lysis with 32P-SFV for 90 min at 37C.
In control cells, 40% of the cell-associated viral [32P]RNA was
accessible to digestion by the RNase. In cells treated with 10
A.M monensin, <1% of the viral RNA was accessible. This in-
dicated that the nucleocapsids were not released from the pro-
tective viral envelope and transferred into the cytosol.
Effect on Binding and Internalization. As the delivery of
nucleocapsids into the cytosol is blocked by monensin, we used
biochemical and morphological techniques to determine at
which stage in the entry pathway the block occurred. For the
morphological studies, SFV was added to cells for 60 min at 00C,
afterwhich the unbound viruses were washed away and the cells
were warmed to 37TC. Indirect immunofluorescence indicated
Table 1. Low pH-induced bypass of the monensin block
pH 5.5 Incorporation,
Inhibitor treatment cpm x 10-'
None - 3.3
None + 4.7
Monensin, 10 ,uM - 0.1
Monensin, 10 pM + 2.8
A virus inoculum of 60 pfu/cell was allowed to bind for 10 min at
00C. Where-indicated, monensin was present in all media and was in-
cluded in all samples during [3H]uridine labeling. A background (non-
infected cells) of 0.5 x 104 cpm was deducted from all values.
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that, both in control cells and in treated (10 ,M monensin or
3 ,M nigericin) cells, the viral antigens were almost totally
cleared from the cell surfaces within 1 hr and were relocated
into intracellular vacuoles (not shown).
Transmission electron microscopy of thin sections also indi-
cated that normal uptake occurred in the presence of 20 ,M
monensin or 3 AM nigericin. Viruses were seen in coated pits,
coated vesicles, and in large (500 Am) and small uncoated
(150-200 ,m) cytoplasmic vacuoles (Fig. 2). The vacuoles, some
containing only a few virus particles and others packed with
many viruses, were similar in control cells and in monensin- and
nigericin-treated cells.
The quantitative studies with 35S-SFV at low (15 particles per
cell) and high (2.3 x 10' particles per cell) multiplicity of in-
fection (moi) showed that binding to 10 AM monensin-treated
cells in the cold was 5-10% lower than to control cells, and the
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rate of uptake of the prebound viruses upon warming was lower
by 20% (at low moi; see Fig. 3) to 35% (at high moi). The rate
of internalization was also decreased by 30% when SFV (9,000
particles per cell) was added to cells at 370C without prior bind-
ing. Increasing the monensin concentration to 25 AM did not
decrease the rate of uptake further. To determine whether the
decrease in internalization rates was restricted to virus uptake
or whether it reflected a general decrease of cellular pinocytic
activity, we measured the uptake of two fluid phase markers,
horseradish peroxidase (20) and [3H]sucrose (10) in the presence
and absence of10AM monensin. A 50% reduction was observed
in the accumulation of both markers (controls accumulated the
equivalent of 0.44 1ul/hr per 107 cells) which suggested that
fluid pinocytosis was also depressed by the drug. However, the
inhibition observed in virus uptake (20-35%) is too small to
account for the almost total inhibition of infection. Thus, the
primary block to infection cannot be ascribed to inhibition of
binding and internalization but must occur after the viruses
have undergone endocytosis.
Passage of SFV into Lysosomes. The most dramatic differ-
ence between the monensin-treated and control cells shown by
the biochemical uptake assays was the almost total inhibition
of virus protein degradation (Fig. 3). Whereas 25-35% of the[35S]methionine in control cells became acid soluble within 90
min at 37TC, <5% was degraded in the monensin-treated cells.
To determine whether the viruses were transported into the
lysosomal compartment in the presence of monensin (10 MLM),
cells were exposed to 32P-SFV for 90 min and lysed under iso-
tonic conditions, and the postnuclear supernatant was fraction-
ated by free-flow electrophoresis. With cultured human skin
fibroblasts, two prominent peaks of enzyme activities are rou-
tinely obtained with the technique (16). The first, migrating
furthest toward the anode, contains marker enzymes for lyso-
somes-o-N-acetylglucosaminidase and acid (3-glycerophos-
phatase. The second peak contains the majority of the protein
and marker enzymes for other membrane organelles-e.g.,
mitochondria [succinate:3-(4-iodophenyl)-2-(4-nitrophenyl)-5-
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FIG. 2. Entry of SFV into BHK-21 cells in the presence of monen-
sin. SFV was bound to BHK-21 cells (60 min at 00) in the presence
of 2 pM monensin. The cells were washed and then warmed to 37T
in medium containing 20 pM monensin for 20 min. The cells were fixed
and processed for electron microscopy. (a) Viruses in small and large
cytoplasmic vesicles. (x44,000.) (b) Viruses associated with coated-pit
regions of the cell surface. (x 100,000.) (c) Viruses in coated vesicles.
(x76,000.) (Bar = 0.2 gm.) Similar figures were seen in 3 Ium nigeri-
cin-treated cells (not shown).
FIG. 3. The influence of monensin on the binding, endocytosis and
degradation of SFV with BHK-21 cells. Cells were pretreated with
binding medium with or without 10 ,uM monensin for 60 min at 370C.
35SSFV (15 particles per cell) was bound to cells in the presence (B)
or absence (A) of monensin (10 pM) for 1 hr in binding medium at 00C.
The unbound viruses were washed away, and the cells were warmed
to 370C in binding medium (with or without monensin). At given time
points, the cells were assayed for total cell-associated activity and for
proteinase K-resistant activity, and the medium was assayed for de-
graded activity as described. o, Total cell-associated activity, including
degraded (medium trichloroacetic acid soluble) activity; e, total inter-
nalized activity (i.e., proteinase K-resistant plus degraded activity);
A, degraded activity.
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phenyl-2H-tetrazolium chloride (INT) oxidoreductase (EC
1.3.99.1)], endoplasmic reticulum (NADPH-cytochrome c re-
ductase), plasmalemma (Na+K+-ATPase), and Golgi (UDPga-
lactose-glycoprotein galactosyltransferase) (16). With a BHK-21
cell lysate, a similar separation was observed,(Fig. 4 Upper). The
fractions containing lysosomes showed 22-fold enrichment of f3-
N-acetylglucosaminidase over the initial lysate and in excess of
90% latency of this enzyme. Thin-section electron microscopy
of a pellet derived from the lysosomal fractions showed a rela-
tively homogeneous population of secondary lysosomes.
Analysis of the 32p activity associated with the fractions in-
dicated that =30% of the viral activity cofractionated with the
lysosomes in. monensin-treated cells (Fig. 4), NH4CI-treated
cells, and control cells. The results suggest that monensin and
NH4Cl do not prevent virus transport into lysosomes; however,
we have no reliable markers for endosomes that may contam-
inate the lysosomal fractions. Whether the viral 32P activity that
is not in the lysosomal fraction is associated with endosomes
remains to be determined.
Relationship with NH4Cl-Induced Inhibition. Lysosomo-
tropic weak bases, such as NH4Cl, inhibit SFV infection by el-
evating the pH in intracellular vacuoles to values higher than
that needed to trigger the fusion reaction (15, 21, 22). To test
whether inhibition by monensin and NH4Cl occur at the same
stage of virus entry, we adopted a strategy used by Marnell et
al. to study diphtheria toxin penetration (8). These experiments
rely on the reversibility of both inhibitors and on the assump-
tion that they affect single steps in the pathway. If inhibitor I
acts prior to inhibitor II, incubation of cells and viruses with I
and subsequently with II should not lead to infection; however,
incubation in the reverse order should permit infection. If I and
II affect the same step, no infection should occur regardless of
the order in which the inhibitors are applied.
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FIG. 4. Fractionation of BHK-21 cells infected with 32P-SFV inthe
presence of monensin. Cells, on 850-cm2 roller bottles, were pretreated
with binding medium containing 10 pM monensin for 30 min at 37°C.
32PSFV in this medium with monensin was incubated with the cells
for 60 min at 37°C, the unbound virus was washed away, and the cells
were incubated for a further 30 min in virus-free binding medium with
monensin at 37°C. Subsequently the cells were harvested, lysed, and
fractionated by free-flow electrophoresis (16). Each fraction was as-
sayed for total protein content (a), for ,B-N-acetylglucosaminidase by
measurement of A412. (0), for succinate:INT oxidoreductase by mea-
surement of A490 (A) as described (16), and for 32P activity (0). Of the
initial cell-associated 32P activity, 64% remained for fractionation; of
this, 79% was recovered. For cell protein, 50% was fractionated and
74% was recovered; for succinate:INT oxidoreductase, 52% was frac-
tionated and 80% was recovered; and for (-N-acetylglucosaminidase,
67% was fractionated and 99% was recovered.
Table 2. Concurrence of monensin and NH4Cl inhibition
Incubation 1 Incubation 2
Exp. (60 min) (120 min) 3H, cpm x 10-4
Control None None 15.5 (100%)
Mon Mon 0
NH4Cl NH4Cl 0
Reversibility Mon None 7.5 (48%)
NH4Cl None 9.9 (64%)
Substitution Mon NH4Cl 0
NH4Cl Mon 0
Substitution Mon, NH4Cl None 5.6 (36%)
and
reversibility* NH4C1, Mon None 5.9 (38%)
Mon, monensin. The monensin was 10 uM, NH4Cl was 15 mM, and
the SFV inoculum was 20 pfu/cell. [3H]uridine and 10 IM monensin
were added to all samples for 2 hr after incubation 2. Figures in brack-
ets express the percentage of the uninhibited control.
* Incubation 1 includes infection of the cell in the presence of the first
inhibitor for 60 min, followed by a 60-min treatment with the second
inhibitor.
First we demonstrated that monensin inhibition is reversi-
ble. Pretreated cells were incubated with SFV in the presence
of 10 ,.uM monensin for 60 min at 37°C. Monensin-free medium
was added, and the cells were incubated for a further 2 hr before
[3H]uridine labeling. We measured 50% infection compared to
that in inhibitor-free control cells (Table 2). Cells treated with
monensin throughout were fully inhibited. The reversibility of
NH4Cl inhibition has been demonstrated (15); in the present
case, we recorded 60% infection after removal of NH4Cl (15
mM).
Two types of double inhibition experiments are shown in
Table 2. In substitution experiments, cells were infected in the
presence of one inhibitor for 60 min and then treated with the
second inhibitor for the remainder of the experiment. No la-
beling occurred with either combination of inhibitors. Second,
in substitution and reversion experiments, cells were infected
in the presence of the first inhibitor for 60 min, then treated
with the second for a further 60 min, and finally returned to
inhibitor-free medium for 2 hr before addition of [3H]uridine.
Almost identical levels of incorporation (36% and 38%) were
observed irrespective of which inhibitor was used first. These
results suggest that monensin and NH4Cl block the same step
in the infection process.
DISCUSSION
Lysosomotropic weak bases inhibit SFV penetration by increas-
ing the pH in the acid vacuoles of the endocytic pathway (9, 15,
21, 22). When the pH exceeds a value of 6, the viruses endo-
cytosedby the cell are unable to fuse with vacuolar membranes,
and the nucleocapsids do not reach the cytoplasmic matrix for
replication (12, 15). Our results suggest that monensin inhibits
SFV entry into BHK-21 cells by a similar mechanism. With both
monensin and the lysosomotropic weak bases (9, 10, 12, 15), we
observe no direct virucidal effect and no inhibition of the viral
membrane fusion-activity, provided that the pH is properly low-
ered. Endocytosis and intracellular transport appear to function
normally, although with monensin a partial inhibition of overall
cellular pinocytic activity and virus uptake was observed. The
block to virus entry imposed by both types of inhibitor can be
circumvented readily by low pH-induced virus fusion at the
plasma membrane (12), and substitution experiments indicate
that monensin and NH4Cl inhibit entry at the same stage. The
conclusion.that the main inhibitory effect involves a failure to
trigger the low pH-dependent fusion in intracellular vacuoles
and lysosomes is consistent with the observation ofOhkuma and
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Poole (21) that both types of agent increase the lysosomal pH.
Carboxylic ionophores collapse the proton gradient by trans-
membrane exchange of protons for monovalent cations (1), and
the lysosomotropic weak bases act as proton traps (see ref. 2).
These results are quite similar to those of Marnell et al. (8),
who have studied the inhibition of diphtheria toxin entry by
monensin. The toxin enters cells by endocytosis, followed by
a low pH-dependent penetration of the toxic A subunit that can
be blocked both by monensin and lysosomotropic weak bases
(8, 23, 24). Monensin also has been shown to inhibit infection
by vesicular stomatitis virus into Swiss 3T3 mouse cells (7). This
enveloped virus infects cells by a mechanism similar to SFV
(25), and its entry is sensitive to lysosomotropic weak bases
(25-27). However, Schlegel et al. (7) attribute the primary in-
hibition of entry to a decreased rate of virus endocytosis. We
also observe a decrease in endocytosis, but the effect is not large
enough to account for the comparatively high inhibition of SFV-
infection. Whether a true difference in the action of monensin
exists between the two virus systems is not clear. However, it
is evident that carboxylic ionophores, depending on dosage,
time of action, and conditions, may affect a variety of cellular
functions (2-6) and, although our results show that the main
effect on SFV entry occurs at the level of penetration, other
effects may indeed contribute to the overall levels ofinhibition.
One of the most striking effects of monensin is the almost
complete inhibition of degradation of virus proteins in the cell.
Inhibition of degradation of low density lipoprotein in monen-
sin-treated cells has been shown by Basu et aL (5). Two possible
explanations could account for this effect-either the lysosomal
hydrolases are inhibited by the drug or the delivery ofvirus into
the lysosomal compartment is impaired. The fact that similar
amounts of viral radioactivity were found in the lysosomal peak
after cell fractionation of monensin-treated, ammonium chlo-
ride-treated, and control cells suggests that delivery to lyso-
somes is not impaired. However, these conclusions must re-
main somewhat tentative, as we do not yet know the endosomal
contamination of our lysosome fractions.
It is interesting that 70% of the intracellular viruses are not
in lysosomes at 90 min. We have assumed in our previous stud-
ies that the acid vacuoles from which penetration occurs are
secondary lysosomes. However, our kinetic results suggest that
the viruses enter a low pH compartment as early as 2-4 min
after leaving the cell surface (9, 28). Thus, the initial acid en-
counter and the resulting membrane fusion reaction appear to
take place very early and may involve prelysosomal vacuoles
(endosomes). In fact, the viruses that enter the secondary ly-
sosomes may represent particles that have failed to fuse in the
endosomes. The relationship between endosomes and lyso-
somes in the process of virus entry and endocytosis in general
presents an intriguing problem. Carboxylic ionophores may
provide a useful tool in the detailed dissection of the pathway.
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